Skip to main content
Equibles

LAZARI CAPITAL MANAGEMENT, INC.

Position in MESO — Mesoblast Ltd

CIK 1986389 WOODLAND HILLS, CA
Back to MESO Full portfolio

Position in MESO

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$641,606
-$67,734 QoQ
Shares Held
47,421
+2.8% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#13
of 72 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LAZARI CAPITAL MANAGEMENT, INC. holds $860,649 across 6 Biotechnology names. MESO ranks #1 (74.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MESO
Mesoblast Ltd
This page 		47,421 $641,606
2 GERN
Geron Corp
 117,424 $150,302
3 MAIA
MAIA Biotechnology, Inc.
 21,750 $31,320
4 LCTX
Lineage Cell Therapeutics, Inc.
 10,500 $13,755
5 VANI
Vivani Medical, Inc.
 10,000 $12,400
6 HUMA
Humacyte, Inc.
 14,444 $11,266

All Filings in MESO

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $641,606 47,421
2026-03-31 $709,340 46,121
2025-12-31 $832,022 46,121
2025-09-30 $751,869 46,671
2025-06-30 $506,069 46,471
2025-03-31 $567,440 45,468
2024-12-31 $900,246 45,467
2024-09-30 $371,465 45,467
2024-06-30 $364,110 53,467
2024-03-31 $251,336 50,167
2023-12-31 $104,977 95,434
2023-09-30 $115,661 94,034
2023-06-30 $336,392 86,034